국가: 헝가리
언어: 영어
출처: HMA (Heads of Medicines Agencies)
enrofloxacin 25 mg/ml
Bayer Vital GmbH
QJ01MA90
Oral suspension
enrofloxacin
Cats
2011-03-23
1 _[Version 10.05/2010] _ ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Baytril flavour 25 mg/ml oral suspension for cat (all MS except FR, DK, FI, IS, NO, SE and ES) (The product name will be translated into national languages) Baytril 2,5% suspension buvable pour chat (FR) Baytril Sabor 25 mg/ml suspensión oral para gatos (ES) Lorenax vet. 25 mg/ml oral suspension for cat ( DK), Baytril vet. 25 mg/ml oral suspension for cat (FI, IS, NO and SE) Enrofloxacin 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each ml of the product contains: ACTIVE SUBSTANCE: Enrofloxacin 25 mg EXCIPIENTS: Ascorbic acid (E300) 0.2 mg Sorbic acid (E200) 2 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension White to yellow-white suspension 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cat 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of single or mixed bacterial infections of the respiratory, alimentary and urinary tract, skin or wounds caused by the following enrofloxacin-sensitive Gram-negative and Gram-positive bacteria: _E.coli, Pasteurella spp, Haemophilus spp. _and_ staphylococci. _ 4.3 CONTRAINDICATIONS 3 Do not use in Animals with existing impairment of cartilage growth Animals with a known history of seizures_, _since enrofloxacin may cause CNS stimulation. Animals with known hypersensitivity to fluoroquinolones or any of the excipients For use in pregnant animals see section 4.7 and for interactio 전체 문서 읽기